Drug Shortage Report for ADENOSINE INJECTION

Last updated on 2022-07-07 History
Report ID 159832
Drug Identification Number 02457474
Brand name ADENOSINE INJECTION
Common or Proper name ADENOSINE INJECTION
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ADENOSINE
Strength(s) 3MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2ML
ATC code C01EB
ATC description OTHER CARDIAC PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-05-02
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-07-07
Company comments Allocations for Adenosine Injection 3 mg/mL prefilled syringe 2 mL will be reducing from 100% demand of 2mL syringe plus 100% demand of 2mL vial to only cover 100% demand of 2mL syringe. Please note, our Adenosine Injection 3 mg/mL SD Vial 2ml is off backorder and available to all customers without restrictions.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-07-07 French Compare
v9 2022-07-07 English Compare
v8 2022-06-06 French Compare
v7 2022-06-06 English Compare
v6 2022-05-03 English Compare
v5 2022-05-02 French Compare
v4 2022-05-02 English Compare
v3 2022-05-02 French Compare
v2 2022-05-02 French Compare
v1 2022-05-02 English Compare

Showing 1 to 10 of 10